PridCor Therapeutics
PrivateCompany Overview
PridCor Therapeutics is a clinical-stage biopharmaceutical company that develops novel antiviral therapies to address infection-associated chronic illnesses, including Long COVID and other viral-driven conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PridCor Therapeutics Comparables
Compare PridCor Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spinogenix, Inc. | 77% | |
| NeuroSense Therapeutics | 74% | |
| Anavex Life Sciences | 67% |
PridCor Therapeutics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Recent news
Latest coverage and updates
- partners_withSep 24, 2026
PridCor Therapeutics, LLC partnered with Icahn School of Medicine at Mount Sinai on Sep 24th '26.
PridCor Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PridCor Therapeutics's valuation, stock price, and market status.
Is PridCor Therapeutics a public or private company?
PridCor Therapeutics is a private company.
What is the current stock price of PridCor Therapeutics?
PridCor Therapeutics is a private company, so its shares have no public market price. Caplight tracks PridCor Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PridCor Therapeutics worth (valuation)?
Valuation information for PridCor Therapeutics is not publicly available.
Can I buy PridCor Therapeutics stock?
PridCor Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PridCor Therapeutics's last funding round?
Funding round information for PridCor Therapeutics is not publicly available.
Who are the main investors in PridCor Therapeutics?
Investor information for PridCor Therapeutics is not publicly disclosed.
Will PridCor Therapeutics IPO soon?
No public IPO plans have been announced for PridCor Therapeutics.
How can I track PridCor Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in PridCor Therapeutics's shares on secondary markets.